|
TWI330183B
(en)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
BR0306919A
(en)
|
2002-01-28 |
2004-11-09 |
Kyowa Hakko Kogyo Kk |
Methods for reducing or suppressing the adverse effectiveness of l-dopa and / or dopamine agonist therapy, and for moderate l-dopa treatment, composition for moderate l-dopa treatment, method for treating parkinson's disease and / or complications. -dopa motors, composition for the treatment of parkinson's disease, and methods for prolonging the effective treatment of parkinson's disease, and for treating movement disorders
|
|
AU2002950853A0
(en)
*
|
2002-08-19 |
2002-09-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminopyrimidine compound and pharmaceutical use thereof
|
|
US20040067955A1
(en)
*
|
2002-09-06 |
2004-04-08 |
Fujisawa Pharmaceutical Co. Ltd. |
Pyridazinone compound and pharmaceutical use thereof
|
|
BRPI0415863A
(en)
*
|
2003-10-27 |
2007-01-09 |
Astellas Pharma Inc |
pyrazine derivatives and their pharmaceutical uses
|
|
ES2241496B1
(en)
*
|
2004-04-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
NEW DERIVATIVES OF PIRIDINA.
|
|
EP1807396B1
(en)
*
|
2004-10-29 |
2013-06-26 |
Merck Sharp & Dohme Corp. |
2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
DE102004061288A1
(en)
*
|
2004-12-14 |
2006-06-29 |
Schering Ag |
New 3-amino-pyrazolo(3,4b)pyridine derivatives are protein tyrosine kinases inhibitors useful e.g. for treating hyperproliferation of body cells, neurodegenerative disease, blood vessel disease and angiogenic disease
|
|
MX2007014114A
(en)
|
2005-05-10 |
2008-03-14 |
Intermune Inc |
Pyridone derivatives for modulating stress-activated protein kinase system.
|
|
WO2007011760A2
(en)
*
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
|
ES2270715B1
(en)
*
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
NEW DERIVATIVES OF PIRAZINA.
|
|
ES2274712B1
(en)
*
|
2005-10-06 |
2008-03-01 |
Laboratorios Almirall S.A. |
NEW IMIDAZOPIRIDINE DERIVATIVES.
|
|
ES2273599B1
(en)
|
2005-10-14 |
2008-06-01 |
Universidad De Barcelona |
COMPOUNDS FOR THE TREATMENT OF HEADPHONE FIBRILATION.
|
|
TWI417095B
(en)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
|
|
US20080009623A1
(en)
*
|
2006-07-06 |
2008-01-10 |
Eisai R&D Management Co., Ltd. |
Pyrimidine compounds
|
|
ES2303776B1
(en)
*
|
2006-12-29 |
2009-08-07 |
Laboratorios Almirall S.A. |
DERIVATIVES OF 5-PHENYL-6-PIRIDIN-4-IL-1,3-DIHIDRO-2H-IMIDAZO (4,5-B) PIRIDIN-2-ONA USEFUL AS ANTAGONISTS OF ADENOSINE A2B RECEIVER.
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
ES2356032T3
(en)
|
2007-09-14 |
2011-04-04 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
4-PHENYL-3,4,5,6-TETRAHIDRO-2H, 1'H- [1,4 '] BIPIRIDINIL-2'-ONAS 1,3'-DISUSTITUTED.
|
|
EA014100B1
(en)
*
|
2008-02-21 |
2010-08-30 |
Общество С Ограниченной Ответственностью "Валексфарм" |
2,4-diaminopyridine derivatives, pharmaceutical composition, medicament based thereon for treating and preventing diseases and disorders caused by nmda-receptors hyperactivation and/or as stimulators of cognitive function and method of treatment
|
|
ES2567283T3
(en)
*
|
2008-06-03 |
2016-04-21 |
Intermune, Inc. |
Compounds and methods to treat inflammatory and fibrotic disorders
|
|
CN102232074B
(en)
|
2008-11-28 |
2014-12-03 |
奥梅-杨森制药有限公司 |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
BRPI1010831A2
(en)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
1,2,4-triazolo [4,3-a] pyridine derivatives and their as positive allosteric modulators of mglur2 receptors
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
MY161325A
(en)
|
2009-05-12 |
2017-04-14 |
Janssen Pharmaceuticals Inc |
1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
|
ES2552455T3
(en)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
WO2012062751A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
ES2552879T3
(en)
|
2010-11-08 |
2015-12-02 |
Janssen Pharmaceuticals, Inc. |
1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
JP6215315B2
(en)
*
|
2012-06-12 |
2017-10-18 |
アッヴィ・インコーポレイテッド |
Pyridinone and pyridazinone derivatives
|
|
AR092742A1
(en)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
ANTIFIBROTIC PYRIDINONES
|
|
BR112015007182A2
(en)
*
|
2012-10-05 |
2017-07-04 |
Rigel Pharmaceuticals Inc |
gdf-8 inhibitors
|
|
TWI644899B
(en)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Flap modulators
|
|
EP2951170B1
(en)
|
2013-02-04 |
2018-10-24 |
Janssen Pharmaceutica NV |
Flap modulators
|
|
JO3368B1
(en)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
ES2784489T3
(en)
*
|
2013-06-27 |
2020-09-28 |
Lg Chemical Ltd |
Biaryl derivatives as GPR120 agonists
|
|
JO3367B1
(en)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
EP3080132A4
(en)
|
2013-12-10 |
2017-08-02 |
AbbVie Inc. |
Bromodomain inhibitors
|
|
KR20200126026A
(en)
|
2014-01-21 |
2020-11-05 |
얀센 파마슈티카 엔.브이. |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
EP3431106B1
(en)
|
2014-01-21 |
2020-12-30 |
Janssen Pharmaceutica NV |
Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use
|
|
CN103804312B
(en)
*
|
2014-02-17 |
2016-04-20 |
四川百利药业有限责任公司 |
Aza cyclic cpds and its production and use
|
|
EP3126362B1
(en)
|
2014-04-02 |
2022-01-12 |
Intermune, Inc. |
Anti-fibrotic pyridinones
|
|
ES2580702B1
(en)
*
|
2015-02-25 |
2017-06-08 |
Palobiofarma, S.L. |
2-Aminopyridine derivatives as adenosine A2b receptor antagonists and MT3 melatonin receptor ligands
|
|
JP2017149663A
(en)
*
|
2016-02-24 |
2017-08-31 |
株式会社Ｌｔｔバイオファーマ |
Irritable bowel syndrome therapeutic agent
|
|
MX2020003732A
(en)
*
|
2017-09-28 |
2021-06-29 |
Cstone Pharmaceuticals Suzhou Co Ltd |
Fused ring derivative as a.
|
|
JP7474709B2
(en)
*
|
2018-02-27 |
2024-04-25 |
インサイト・コーポレイション |
Imidazopyrimidines and triazolopyrimidines as A2A/A2B inhibitors
|
|
CN110240593A
(en)
*
|
2018-03-09 |
2019-09-17 |
四川科伦博泰生物医药股份有限公司 |
Substituted aromatic amines compound and its preparation method and application
|
|
CN111018858B
(en)
*
|
2018-10-10 |
2022-11-18 |
复旦大学 |
Heterocyclic derivative and preparation method and application thereof
|
|
EP3904348A4
(en)
*
|
2018-12-28 |
2022-10-19 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Aminopyridine compound, preparation method therefor and use thereof
|
|
CN111035638A
(en)
*
|
2019-06-24 |
2020-04-21 |
南开大学 |
A medicine containing adenosine A1/A2AReceptor-selective adenosine A1Receptor antagonists
|
|
WO2022150349A1
(en)
*
|
2021-01-06 |
2022-07-14 |
The Penn State Research Foundation |
Methods and materials for treating bone loss
|